Philadelphia-based Rothman Orthopaedic Institute may lose $120 million in revenue this year due to the cessation of elective surgeries caused by the COVID-19 pandemic, the Philadelphia Business Journal reports.
About 800 employees and 60 physicians have been temporarily furloughed, with the practice's April caseload down 90 percent.
Rothman Orthopaedics has racked up more than 4,000 backlogged cases, which it is beginning to reschedule after the Pennsylvania Department of Health on April 27 gave hospitals and ASCs the green light to resume elective surgeries.
The practice's network of ASCs, as well as its two specialty surgical hospitals in Bensalem and Royersford, Pa., will be able to ramp up quickly. Employees will return to these facilities next week, with the practice bringing back more staff as patient volume dictates.
Patient lists are also being submitted to Thomas Jefferson University Hospital in Philadelphia and other area hospitals.
Surgeries for the lowest-risk patients will be scheduled first, with physicians reviewing and discussing the risks and benefits of the procedures with patients, according to Alexander Vaccaro, MD, PhD, the practice's president.